BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 20378575)

  • 1. Splenic marginal zone lymphoma: hydra with many heads?
    Arcaini L; Paulli M
    Haematologica; 2010 Apr; 95(4):534-7. PubMed ID: 20378575
    [No Abstract]   [Full Text] [Related]  

  • 2. CD5 expression identifies a subset of splenic marginal zone lymphomas with higher lymphocytosis: a clinico-pathological, cytogenetic and molecular study of 24 cases.
    Baseggio L; Traverse-Glehen A; Petinataud F; Callet-Bauchu E; Berger F; Ffrench M; Couris CM; Thieblemont C; Morel D; Coiffier B; Salles G; Felman P
    Haematologica; 2010 Apr; 95(4):604-12. PubMed ID: 20015887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of CD5-positive splenic marginal zone lymphoma with leukemic manifestation ; clinical, flow cytometry, and histopathological findings of 11 cases.
    Kojima M; Sato E; Oshimi K; Murase T; Koike T; Tsunoda S; Matsumoto T; Marutsuka K; Ogiya D; Moriuchi M; Tokunaka M; Yara Kikuti Y; Kikuchi T; Nakamura N; Ando K
    J Clin Exp Hematop; 2010; 50(2):107-12. PubMed ID: 21123968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and biological features of B-cell neoplasms with CDK6 translocations: an association with a subgroup of splenic marginal zone lymphomas displaying frequent CD5 expression, prolymphocytic cells, and TP53 abnormalities.
    Gailllard B; Cornillet-Lefebvre P; Le QH; Maloum K; Pannetier M; Lecoq-Lafon C; Grange B; Jondreville L; Michaux L; Nadal N; Ittel A; Luquet I; Struski S; Lefebvre C; Gaillard JB; Lafage-Pochitaloff M; Balducci E; Penther D; Barin C; Collonge-Rame MA; Jimenez-Poquet M; Richebourg S; Lemaire P; Defasque S; Radford-Weiss I; Bidet A; Susin SA; Nguyen-Khac F; Chapiro E;
    Br J Haematol; 2021 Apr; 193(1):72-82. PubMed ID: 33314017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA expression profile in splenic marginal zone lymphoma.
    Bouteloup M; Verney A; Rachinel N; Callet-Bauchu E; Ffrench M; Coiffier B; Magaud JP; Berger F; Salles GA; Traverse-Glehen A
    Br J Haematol; 2012 Jan; 156(2):279-81. PubMed ID: 21902683
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinicopathological features of CD5-positive splenic marginal zone lymphoma.
    Li Y; Wang G; Liu E; Zhang D; Zhang Y; Jian X; Zhao W; Li W
    J Clin Pathol; 2024 May; 77(6):421-425. PubMed ID: 36922019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Splenic marginal zone lymphoma.
    Piris MA; Onaindía A; Mollejo M
    Best Pract Res Clin Haematol; 2017; 30(1-2):56-64. PubMed ID: 28288718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinicopathologic features and differential diagnosis of splenic B-cell marginal zone lymphoma involving bone marrow].
    Sun Q; Zhang PH; Liu EB; Liu W; Li ZQ; Yang QY; Fang LH; Sun FJ; Chen HS; Qiu LG
    Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):234-8. PubMed ID: 23928529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Splenic B-cell lymphomas with more than 55% prolymphocytes in blood: evidence for prolymphocytoid transformation.
    Hoehn D; Miranda RN; Kanagal-Shamanna R; Lin P; Medeiros LJ
    Hum Pathol; 2012 Nov; 43(11):1828-38. PubMed ID: 22520947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD5+ extranodal marginal zone B-cell (MALT) lymphoma.
    Wright DH
    Am J Clin Pathol; 1996 Sep; 106(3):438. PubMed ID: 8816603
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinicopathologic study of splenic marginal zone B-cell lymphoma].
    Zhang YN; Zheng YY; Zhou XG; Zhang SH; Jin Y; Xie JL; Chen SY; Shi Y; Wu LH
    Zhonghua Bing Li Xue Za Zhi; 2009 Apr; 38(4):243-7. PubMed ID: 19575895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Composite splenic marginal zone lymphoma and classic Hodgkin lymphoma -- an unusual combination.
    Elmahy H; Hawley I; Beard J
    Int J Lab Hematol; 2007 Dec; 29(6):461-3. PubMed ID: 17988302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Splenic lymphoma, diagnosis and treatment].
    Riller Q; Cohen-Aubart F; Roos-Weil D
    Rev Med Interne; 2022 Oct; 43(10):608-616. PubMed ID: 35691756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical Expression of Lymphoid Enhancer Binding Factor 1 in CD5-Positive Marginal Zone, Lymphoplasmacytic, and Follicular Lymphomas.
    Patel N; Durkin L; Bodo J; Hsi ED
    Am J Clin Pathol; 2020 Apr; 153(5):646-655. PubMed ID: 31953940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the simplified prognostic score for splenic marginal zone lymphoma of the Splenic Marginal Zone Lymphoma Working Group.
    Kalpadakis C; Pangalis GA; Angelopoulou MK; Sachanas S; Kontopidou F; Moschogiannis M; Ximeri M; Tsirkinidis P; Yiakoumis X; Papadaki HA; Vassilakopoulos TP
    Leuk Lymphoma; 2014 Nov; 55(11):2640-2. PubMed ID: 24576167
    [No Abstract]   [Full Text] [Related]  

  • 16. [Splenic pathology. Case no 2. Splenic marginal zone B-cell lymphoma].
    Traverse-Glehen A; Berger F
    Ann Pathol; 2010 Jun; 30(3):206-10. PubMed ID: 20621598
    [No Abstract]   [Full Text] [Related]  

  • 17. Higher expression levels of activation-induced cytidine deaminase distinguish hairy cell leukemia from hairy cell leukemia-variant and splenic marginal zone lymphoma.
    Hockley SL; Morilla A; Else M; Dearden C; Catovsky D; Morgan GJ; Matutes E; Gonzalez D
    Leukemia; 2010 May; 24(5):1084-6. PubMed ID: 20237507
    [No Abstract]   [Full Text] [Related]  

  • 18. Splenic marginal zone B-cell lymphoma: a distinct clinicopathological and molecular entity. Recent advances in ontogeny and classification.
    Traverse-Glehen A; Baseggio L; Salles G; Felman P; Berger F
    Curr Opin Oncol; 2011 Sep; 23(5):441-8. PubMed ID: 21760505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-like receptor stimulation in splenic marginal zone lymphoma can modulate cell signaling, activation and proliferation.
    Fonte E; Agathangelidis A; Reverberi D; Ntoufa S; Scarfò L; Ranghetti P; Cutrona G; Tedeschi A; Xochelli A; Caligaris-Cappio F; Ponzoni M; Belessi C; Davis Z; Piris MA; Oscier D; Ghia P; Stamatopoulos K; Muzio M
    Haematologica; 2015 Nov; 100(11):1460-8. PubMed ID: 26294727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Massive intrafollicular and arterial hyalinosis of the spleen following rituximab and methylprednisolone therapy in a patient with splenic marginal zone lymphoma.
    Schaefer IM; Marx A; Sauer C; Hohloch K; Ghadimi BM; Trümper L; Ströbel P
    Histopathology; 2013 Mar; 62(4):664-7. PubMed ID: 23379885
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.